10:00 am - 11:00 am MST
9:00 am - 10:00 am PST
After completing this learning activity, participants will be better able to:
- Review of the key information and new data in hyperkalemia, hyperphosphatemia, and chronic kidney disease associated pruritus (CKD-aP) presented at the ASN Kidney Week 2021
- Reflection on the implications for clinical practice, patient care, and future research
- Sharing of best practices with colleagues
Dalhousie University
Chief Division of Nephrology Eastern Zone Nova Scotia Health
Department of Biomedical and Molecular Sciences at Queen's University
Dr. Rachel M. Holden is a nephrologist and a Professor in the Department of Medicine with a cross-appointment to the Department of Biomedical and Molecular Sciences at Queen's University. She joined the faculty in 2001.
Dr. Holden and her associates study basic mechanisms of vascular calcification in chronic kidney disease. She is particularly interested in the role of phosphate as novel risk factor for cardiovascular disease in the general population.
A major focus of her research program is clinical, basic and translational aspects of vitamin K metabolism and specifically the role of vitamin K in the inhibition of vascular calcification. She is currently leading the CIHR-funded iPACK-HD clinical trial – a randomized controlled trial that will evaluate whether vitamin K supplementation attenuates the progression of calcification in patients with end stage kidney disease.
Dr. Holden's clinical interests include mineral bone disorders in chronic kidney disease and hemodialysis patients.
Medical lead for the Fraser Health peritoneal dialysis program
Daniel Schwartz is a practicing nephrologist at the Royal Columbia Hospital and medical lead for the Fraser Health peritoneal dialysis program.
He received his training at the University of British Columbia and University of Toronto. His clinical interests are focused on peritoneal dialysis, interventional nephrology and advanced CKD management.
He also has a keen interest in knowledge translation at the point of care and the intersection of information technology with clinical medicine.